Literature DB >> 22902437

[A guideline for antimetics use for patients with malignancies].

Yoshiki Horie1, Narikazu Boku.   

Abstract

Although recent advances in chemotherapy have led to improvement of QOL and prolonged survival for patients with advanced cancer, we often cannot continue treatments because of adverse events, even though the drug is effective. To obtain the maximum effect from chemotherapy, it is important to control the nausea and vomiting associated with it using an effective antiemetic therapy. In Japan, guidelines for the proper use of antimetics were announced in May 2010 by the Japan Society of Clinical Oncology, supported by the Ministry of Health, Labour and Welfare. Here, we introduce outline of this guideline for antimetics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22902437

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer.

Authors:  Michiyasu Murakami; Hiroki Hashimoto; Kyohei Yamaguchi; Ikuko Yamaguchi; Shozo Senba; Takeshi Siraishi
Journal:  Support Care Cancer       Date:  2013-11-16       Impact factor: 3.603

2.  Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.

Authors:  Hiroaki Kimura; Norio Yamamoto; Toshiharu Shirai; Hideji Nishida; Katsuhiro Hayashi; Yoshikazu Tanzawa; Akihiko Takeuchi; Kentaro Igarashi; Hiroyuki Inatani; Shingo Shimozaki; Takashi Kato; Yu Aoki; Takashi Higuchi; Hiroyuki Tsuchiya
Journal:  Cancer Med       Date:  2014-12-23       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.